Mar 8 |
On International Women's Day, Organon Canada is encouraging businesses to Invest in HER and help address gender inequities through women's health
|
Feb 24 |
Organon Stock Is Still Worth A Look
|
Feb 20 |
Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary
|
Feb 16 |
Organon Q4 And Full Year 2023 Earnings Review - Positive Updates At Last
|
Feb 15 |
Why Herbalife Shares Are Trading Lower By Around 36%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
|
Feb 15 |
Organon & Co. (OGN) Q4 2023 Earnings Call Transcript
|
Feb 15 |
Organon nears five-month high after Q4 beat
|
Feb 15 |
Organon & Co. 2023 Q4 - Results - Earnings Call Presentation
|
Feb 15 |
Organon in charts: Biosimilars revenue rises by ~49% and Women’s Health revenue by 7% in Q4
|
Feb 15 |
Organon beats top-line and bottom-line estimates; initiates FY24 outlook
|